Correction to: Efficacy, tolerability and safety of darbepoetin alfa injection for the treatment of anemia associated with chronic kidney disease (CKD) undergoing dialysis: a randomized, phase-III trial

被引：0
|
作者：
Shubhadeep D. Sinha
Vamsi Krishna Bandi
Bala Reddy Bheemareddy
Pankaj Thakur
Sreenivasa Chary
Kalpana Mehta
Vikranth Reddy Pinnamareddy
Rajendra Pandey
Subhramanyam Sreepada
Santosh Durugkar
机构：
[1] Clinical Development and Medical Affairs,Department of Nephrology
[2] Hetero Group,Department of Nephrology
[3] Hetero Corporate,undefined
[4] B.L.Y Nair Hospital,undefined
[5] Care Hospitals,undefined
[6] Institute of Post Graduate Medical Education and Research Kolkata,undefined
[7] Sri Raghavendra Hospital,undefined
[8] Ashwini Hospital and Ramakanth Heart Care Center,undefined
来源：
BMC Nephrology | / 20卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Following publication of the original article [1], the authors reported errors in the presentation of Tables 2, 4 and 5.
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of cancer: A controlled, randomized, open-label phase II trial
    Charu, Veena
    Belani, Chandra P.
    Gill, Ahmad N.
    Bhatt, Mukesh
    Tomita, Dianne
    Rossi, Greg
    Ben-Jacob, Ali
    ONCOLOGIST, 2007, 12 (06): : 727 - 737
  • [32] Corrigendum: Darbepoetin alfa injection versus epoetin alfa injection for treating anemia of Chinese hemodialysis patients with chronic kidney failure: A randomized, open-label, parallel-group, non-inferiority phase III trail
    慢性疾病与转化医学(英文), 2024, (01)
  • [33] Efficacy and safety of daprodustat versus darbepoetin alfa in the treatment of anemia in chronic renal failure: Systematic review and meta-analysis of randomized controlled trials
    Pang, Shuyue
    Wang, Zhongtian
    Fu, Yanyan
    Huang, Xu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2025, 158 (01) : 68 - 75
  • [34] Prospective, Randomized evaluation of extended epoetin alfa dosing for treatment of anemia of chronic kidney disease (CKD): PROMPT interim analysis.
    Provenzano, R
    Bhaduri, S
    Tang, KL
    Klausner, M
    Singh, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 457A - 458A
  • [35] Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study
    Sinha, Shubhadeep D.
    Bandi, Vamsi K.
    Reddy, Bala B.
    Thakur, Pankaj
    Chary, Sreenivasa
    Talluri, Leela
    Kakkunnath, Sheejith
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [36] CERA ONCE EVERY 4 WEEKS (Q4W) CORRECTS ANAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) NOT ON DIALYSIS AND DEMONSTRATES COMPARABLE SAFETY TO DARBEPOETIN ALFA
    Roger, S.
    NEPHROLOGY, 2010, 15 : 79 - 80
  • [37] Roxadustat for the treatment of anemia in chronic kidney disease (CKD) patients not on dialysis (NDD): a phase 3, randomized, open-label, active-controlled study
    Barratt, Jonathan
    Andric, Branislav
    Tataradze, Avtandil
    Schomig, Michael
    Reusch, Michael
    Valluri, Udaya
    SWISS MEDICAL WEEKLY, 2020, : 9S - 9S
  • [38] Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Akizawa, Tadao
    Iwasaki, Manabu
    Otsuka, Tetsuro
    Reusch, Michael
    Misumi, Toshihiro
    ADVANCES IN THERAPY, 2019, 36 (06) : 1438 - 1454
  • [39] Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial
    Tadao Akizawa
    Manabu Iwasaki
    Tetsuro Otsuka
    Michael Reusch
    Toshihiro Misumi
    Advances in Therapy, 2019, 36 : 1438 - 1454
  • [40] Efficacy and safety of Vadadustat in the treatment of anemia associated with chronic kidney disease: insights from clinical trials
    Ikponmwosa Jude Ogieuhi
    Gbolahan Olatunji
    Emmanuel Kokori
    Adegbesan Abiodun Christopher
    Adewunmi Akingbola
    Ikpembhosa Esangbedo
    God-dowell O. Odukudu
    Adedoyin Esther Alao
    Oluwafemi Isaiah Ajimotokan
    Luboom Tesema Taa
    Oshomoh Mark-Anthony Ugiomoh
    Babatunde Olusola Daniel
    Nicholas Aderinto
    Discover Medicine, 1 (1):
12345